Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)
This study has been withdrawn prior to enrollment.
( Sponsor decision to withdraw study to pursue others. )
Study NCT01339949 Information provided by Oraya Therapeutics, Inc.
First Received on April 20, 2011. Last Updated on December 28, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Age-related Macular Degeneration
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial
Oraya Therapeutics, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers